kneat.com (TSE:KSI) Sets New 52-Week High – Here’s Why

kneat.com, inc. (TSE:KSI) hit a new 52-week high on Wednesday . The company traded as high as C$6.53 and last traded at C$6.45, with a volume of 128055 shares. The stock had previously closed at C$6.39.

Analyst Upgrades and Downgrades

Several analysts have issued reports on KSI shares. Cibc World Mkts raised kneat.com to a “strong-buy” rating in a research note on Tuesday, October 29th. CIBC set a C$6.00 price objective on kneat.com and gave the stock an “outperform” rating in a report on Tuesday, October 29th.

kneat.com Stock Performance

The stock’s 50-day moving average price is C$5.86 and its 200 day moving average price is C$5.10. The firm has a market cap of C$543.52 million, a P/E ratio of -39.50, a price-to-earnings-growth ratio of 597.67 and a beta of 1.08. The company has a debt-to-equity ratio of 95.14, a current ratio of 1.47 and a quick ratio of 1.50.

kneat.com (TSE:KSI) last issued its quarterly earnings results on Wednesday, November 6th. The company reported C$0.01 EPS for the quarter, topping the consensus estimate of C($0.05) by C$0.06. kneat.com had a negative net margin of 31.19% and a negative return on equity of 51.13%. During the same quarter in the previous year, the firm posted ($0.05) EPS. As a group, equities analysts predict that kneat.com, inc. will post -0.12 EPS for the current year.

kneat.com Company Profile

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.